Icon Advisers’s Edwards Lifesciences EW Stock Holding History

Icon Advisers’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,300	Closed	-$574K	–	200
2020 Q2	$574K	Sell	8,300 -2,800	-25%	-$199K	0.11%	190
2020 Q1	$698K	Hold	11,100	–	–	0.15%	166
2019 Q4	$863K	Hold	11,100	–	–	0.12%	201
2019 Q3	$814K	Hold	11,100	–	–	0.12%	213
2019 Q2	$684K	Sell	11,100 -17,400	-61%	-$1.05M	0.06%	233
2019 Q1	$1.82M	Sell	28,500 -10,500	-27%	-$599K	0.18%	129
2018 Q4	$1.99M	Hold	39,000	–	–	0.21%	120
2018 Q3	$2.26M	Hold	39,000	–	–	0.19%	124
2018 Q2	$1.89M	Hold	39,000	–	–	0.14%	136
2018 Q1	$1.81M	Sell	39,000 -29,400	-43%	-$1.28M	0.14%	156
2017 Q4	$2.57M	Sell	68,400 -17,400	-20%	-$639K	0.18%	128
2017 Q3	$3.13M	Sell	85,800 -80,700	-48%	-$3.08M	0.22%	131
2017 Q2	$6.56M	Hold	166,500	–	–	0.46%	72
2017 Q1	$5.22M	Sell	166,500 -81,000	-33%	-$2.54M	0.36%	95
2016 Q4	$7.73M	Buy	+247,500	New	+$8.02M	0.52%	58
2014 Q2	–	Sell	-162,000	Closed	-$2M	–	347
2014 Q1	$2M	Hold	162,000	–	–	0.14%	136
2013 Q4	$1.78M	Buy	+162,000	New	+$1.83M	0.13%	138

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Icon Advisers's EW Position: Q3 2020 in Review

Icon Advisers sold out of Edwards Lifesciences (EW) in Q3 2020, closing a stake of 8,300 shares — an estimated $574K sold.

Icon Advisers first reported a position in EW in Q4 2013 and held it in 17 quarters. The position peaked at $7.73M in Q4 2016. 1,083 funds tracked by Wall St. Rank hold EW as of Q3 2020.

Icon Advisers reported no remaining Edwards Lifesciences position as of Q3 2020 after selling out during the quarter.
Icon Advisers sold 8,300 Edwards Lifesciences shares in Q3 2020, an estimated $574K.
Icon Advisers first reported a position in Edwards Lifesciences in Q4 2013 and held it in 17 quarters.
Icon Advisers's Edwards Lifesciences position peaked at $7.73M in Q4 2016.
1,083 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on Icon Advisers's 13F filing for Q3 2020, filed 5 Nov 2020.